Evolent Health, Inc.EVHNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank46
3Y CAGR-2.8%
5Y CAGR-10.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-2.8%/yr
vs -2.8%/yr prior
5Y CAGR
-10.2%/yr
Recent acceleration
Acceleration
+0.0pp
Accelerating
Percentile
P46
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $287.47M | -29.5% |
| 2024 | $407.84M | -23.3% |
| 2023 | $531.68M | +69.9% |
| 2022 | $312.94M | +6.9% |
| 2021 | $292.82M | -40.4% |
| 2020 | $490.90M | +1.6% |
| 2019 | $482.97M | +37.7% |
| 2018 | $350.82M | +47.4% |
| 2017 | $238.04M | +33.8% |
| 2016 | $177.92M | - |